Hormones & Cancer
Leading citation impact metric from Clarivate Journal Citation Reports
30 papers with at least that number of citations each
State Council for Professorship (HĐGSNN) Scoring
Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)
HĐGSNN Score History
By article publication year| Year | Max Score | Evaluation Details | Source |
|---|---|---|---|
| 2025 | 1.00đ | WoS Q4 | 🔵 Computed |
| 2023 | 1.00đ | WoS Q4(IF: 3) | 🔵 Computed |
| 2022 | 1.00đ | WoS Q4(IF: 4.667) | 🔵 Computed |
| 2021 | 1.00đ | WoS Q4(IF: 3.869) | 🔵 Computed |
| 2020 | 1.00đ | WoS Q4(IF: 2.437) | 🔵 Computed |
| 2019 | 1.00đ | WoS Q4(IF: 2.239) | 🔵 Computed |
| 2018 | 1.00đ | WoS Q4(IF: 2.581) | 🔵 Computed |
Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.
Aims & Scope
Hormones and Cancer is a unique multidisciplinary translational journal featuring basic science, pre-clinical, epidemiological, and clinical research papers. It covers all aspects of the interface of Endocrinology and Oncology. Thus, the journal covers two main areas of research: Endocrine tumors (benign & malignant tumors of hormone secreting endocrine organs) and the effects of hormones on any type of tumor. We welcome all types of studies related to these fields, but our particular attention is on translational aspects of research. In addition to basic, pre-clinical, and epidemiological studies, we encourage submission of clinical studies including those that comprise small series of tumors in rare endocrine neoplasias and/or negative or confirmatory results provided that they significantly enhance our understanding of endocrine aspects of oncology. The journal does not publish case studies.
SCImago & Scopus Journal Intelligence
Not indexed in SCImago / Scopus databaseThis journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
No WoS category details available for this journal.
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
| Year | Impact Factor | Articles / Year | Total Citations |
|---|---|---|---|
| 2023 | 3 | — | — |
| 2022 | 4.667 | — | — |
| 2021 | 3.869 | — | — |
| 2020 | 2.437 | 19 | 416 |
| 2019 | 2.239 | 19 | 627 |
| 2018 | 2.581 | 41 | 1,152 |
| 2017 | — | 35 | 895 |
| 2016 | — | 33 | 1,016 |
| 2015 | — | 34 | 686 |
| 2014 | — | 42 | 1,608 |
| 2013 | — | 38 | 1,021 |
| 2012 | — | 29 | 843 |
| 2011 | — | 39 | 1,550 |
| 2010 | — | 43 | 1,844 |
| 1996 | — | 20 | 75 |
Journal Metrics & Citation Visualizations
Impact Factor Trend (2018–2024)
Clarivate IF trend for Hormones & Cancer
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics